NEW YORK (GenomeWeb News) - Deltadot said today it has received £3 million ($6.1 million) to close a round of private equity funding that it will use to support R&D and marketing.
The company originally announced the funding round in March 2006. The financing announced today is the fourth and final tranche for the round and brings the total funds raised to £6 million ($12.2 million).
The funding was led by Fleming Family & Partners Private Equity, and included investments from Imperial Innovations, NPI Ventures, Sitka Health Fund VCT, and London Technology Fund.
Deltadot’s CEO, Anthony Baxter, said the molecular imaging company will use the capital to ramp up production of its Peregrine high-performance capillary electrophoresis system, to develop capillary and microfluidic technologies such as its Osprey system, and to develop international sales and marketing programs, particularly in the US.